Macquarie Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-15,036
| Closed | -$92K | – | 2679 |
|
2021
Q3 | $92K | Buy |
15,036
+10,857
| +260% | +$66.4K | ﹤0.01% | 2010 |
|
2021
Q2 | $34K | Buy |
4,179
+3,796
| +991% | +$30.9K | ﹤0.01% | 2245 |
|
2021
Q1 | $3K | Sell |
383
-59,080
| -99% | -$463K | ﹤0.01% | 2456 |
|
2020
Q4 | $687K | Sell |
59,463
-4,670
| -7% | -$54K | ﹤0.01% | 1396 |
|
2020
Q3 | $668K | Sell |
64,133
-2,358
| -4% | -$24.6K | ﹤0.01% | 1338 |
|
2020
Q2 | $874K | Buy |
66,491
+1,765
| +3% | +$23.2K | ﹤0.01% | 1239 |
|
2020
Q1 | $509K | Buy |
64,726
+3,764
| +6% | +$29.6K | ﹤0.01% | 1266 |
|
2019
Q4 | $1.26M | Sell |
60,962
-15,554
| -20% | -$322K | ﹤0.01% | 1182 |
|
2019
Q3 | $1.05M | Buy |
76,516
+4,425
| +6% | +$60.7K | ﹤0.01% | 1199 |
|
2019
Q2 | $887K | Buy |
72,091
+2,712
| +4% | +$33.4K | ﹤0.01% | 1245 |
|
2019
Q1 | $866K | Buy |
69,379
+895
| +1% | +$11.2K | ﹤0.01% | 1231 |
|
2018
Q4 | $775K | Buy |
68,484
+1,781
| +3% | +$20.2K | ﹤0.01% | 1219 |
|
2018
Q3 | $1.25M | Buy |
66,703
+6,399
| +11% | +$120K | ﹤0.01% | 1151 |
|
2018
Q2 | $1.56M | Buy |
60,304
+7,020
| +13% | +$181K | ﹤0.01% | 1069 |
|
2018
Q1 | $1.19M | Sell |
53,284
-483
| -0.9% | -$10.8K | ﹤0.01% | 1128 |
|
2017
Q4 | $1.35M | Buy |
53,767
+6,791
| +14% | +$170K | ﹤0.01% | 1151 |
|
2017
Q3 | $1.14M | Sell |
46,976
-8,941
| -16% | -$216K | ﹤0.01% | 1170 |
|
2017
Q2 | $1.13M | Buy |
55,917
+338
| +0.6% | +$6.84K | ﹤0.01% | 1132 |
|
2017
Q1 | $1.5M | Sell |
55,579
-7,906
| -12% | -$213K | ﹤0.01% | 1055 |
|
2016
Q4 | $1.21M | Buy |
63,485
+129
| +0.2% | +$2.45K | ﹤0.01% | 1111 |
|
2016
Q3 | $1.24M | Sell |
63,356
-93,258
| -60% | -$1.82M | ﹤0.01% | 1092 |
|
2016
Q2 | $2.34M | Buy |
+156,614
| New | +$2.34M | ﹤0.01% | 1103 |
|
2016
Q1 | – | Sell |
-48,159
| Closed | -$928K | – | 1608 |
|
2015
Q4 | $928K | Buy |
48,159
+625
| +1% | +$12K | ﹤0.01% | 1093 |
|
2015
Q3 | $706K | Buy |
+47,534
| New | +$706K | ﹤0.01% | 1192 |
|